Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Samsung Biologics (207940.KS)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (Won)	Price Target (Won)	Rating
2021-01-22	785663	-	No Rating
2022-08-08	900000	1070000	Buy
2023-01-28	809000	1060000	Buy
2023-04-12	800000	980000	Buy
2024-01-11	751000	990000	Buy
2024-03-12	840000	1050000	Buy

Disclosures

Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.